Sign in

David Kenneth Motemaden

Senior Managing Director and Senior Equity Research Analyst at Evercore ISI

David Kenneth Motemaden is a Senior Managing Director and Senior Equity Research Analyst at Evercore ISI, specializing in coverage of the U.S. Property & Casualty insurance and Canadian Life insurance sectors. He covers prominent companies such as AON (Aon PLC) and Palomar Holdings, and boasts a strong performance record, ranking among the top analysts with a 75% success rate and an average return per rating of 12.9%. Motemaden began his career in credit risk at Morgan Stanley, later moving to equity research at Credit Suisse and then serving as an investment analyst at Viking Global Investors in London before joining Evercore ISI over a decade ago. He holds a BS in finance from The Pennsylvania State University, is a Chartered Financial Analyst (CFA) charterholder, and maintains relevant professional securities licenses.

David Kenneth Motemaden's questions to ARCH CAPITAL GROUP (ACGL) leadership

Question · Q3 2025

David Kenneth Motemaden asked about the nature of reserve releases, specifically the movement between long-tail and short-tail lines within the insurance and reinsurance segments. He also inquired about the impact of the mix shift towards casualty lines on underlying loss ratios in both segments and its potential future implications.

Answer

François Morin (EVP, CFO, and Treasurer) noted that reserve movements were similar to prior quarters, with small, unsurprising adverse development in casualty, but overall favorable actual versus expected results, and strong performance from short-tail lines. Nicolas Papadopoulo (CEO) explained that while the mix shift to casualty hasn't fundamentally changed yet, it could impact loss ratios down the road, as casualty lines typically have a higher loss peak than short-tail lines.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts